Radiation  ||| S:0 E:10 ||| NN
fibrosis  ||| S:10 E:19 ||| NN
of  ||| S:19 E:22 ||| IN
the  ||| S:22 E:26 ||| DT
vocal  ||| S:26 E:32 ||| JJ
fold ||| S:32 E:36 ||| NN
:  ||| S:36 E:38 ||| :
from  ||| S:38 E:43 ||| IN
man  ||| S:43 E:47 ||| NN
to  ||| S:47 E:50 ||| TO
mouse  ||| S:50 E:56 ||| VB
To  ||| S:56 E:59 ||| TO
characterize  ||| S:59 E:72 ||| VB
fundamental  ||| S:72 E:84 ||| JJ
late  ||| S:84 E:89 ||| JJ
tissue  ||| S:89 E:96 ||| NN
effects  ||| S:96 E:104 ||| NNS
in  ||| S:104 E:107 ||| IN
the  ||| S:107 E:111 ||| DT
human  ||| S:111 E:117 ||| JJ
vocal  ||| S:117 E:123 ||| NNS
fold  ||| S:123 E:128 ||| VBP
following  ||| S:128 E:138 ||| VBG
radiation  ||| S:138 E:148 ||| NN
therapy ||| S:148 E:155 ||| NN
.  ||| S:155 E:157 ||| .
To  ||| S:157 E:160 ||| TO
develop  ||| S:160 E:168 ||| VB
a  ||| S:168 E:170 ||| DT
murine  ||| S:170 E:177 ||| JJ
model  ||| S:177 E:183 ||| NN
of  ||| S:183 E:186 ||| IN
radiation  ||| S:186 E:196 ||| NN
fibrosis  ||| S:196 E:205 ||| NN
in  ||| S:205 E:208 ||| IN
order  ||| S:208 E:214 ||| NN
to  ||| S:214 E:217 ||| TO
ultimately  ||| S:217 E:228 ||| RB
develop  ||| S:228 E:236 ||| VB
both  ||| S:236 E:241 ||| DT
treatment  ||| S:241 E:251 ||| NN
and  ||| S:251 E:255 ||| CC
prevention  ||| S:255 E:266 ||| NN
paradigms ||| S:266 E:275 ||| NN
.  ||| S:275 E:277 ||| .
Translational  ||| S:277 E:291 ||| JJ
study  ||| S:291 E:297 ||| NN
using  ||| S:297 E:303 ||| VBG
archived  ||| S:303 E:312 ||| JJ
human  ||| S:312 E:318 ||| JJ
and  ||| S:318 E:322 ||| CC
fresh  ||| S:322 E:328 ||| JJ
murine  ||| S:328 E:335 ||| FW
irradiated  ||| S:335 E:346 ||| FW
vocal  ||| S:346 E:352 ||| FW
fold  ||| S:352 E:357 ||| FW
tissue.  ||| S:357 E:365 ||| FW
1 ||| S:365 E:366 ||| LS
)  ||| S:366 E:368 ||| -RRB-
Irradiated  ||| S:368 E:379 ||| NNP
vocal  ||| S:379 E:385 ||| JJ
fold  ||| S:385 E:390 ||| JJ
tissue  ||| S:390 E:397 ||| NN
from  ||| S:397 E:402 ||| IN
patients  ||| S:402 E:411 ||| NNS
undergoing  ||| S:411 E:422 ||| VBG
laryngectomy  ||| S:422 E:435 ||| NN
for  ||| S:435 E:439 ||| IN
loss  ||| S:439 E:444 ||| NN
of  ||| S:444 E:447 ||| IN
function  ||| S:447 E:456 ||| NN
from  ||| S:456 E:461 ||| IN
radiation  ||| S:461 E:471 ||| NN
fibrosis  ||| S:471 E:480 ||| NNS
was  ||| S:480 E:484 ||| VBD
identified  ||| S:484 E:495 ||| VBN
from  ||| S:495 E:500 ||| IN
pathology  ||| S:500 E:510 ||| JJ
archives ||| S:510 E:518 ||| NN
.  ||| S:518 E:520 ||| .
Histomorphometry ||| S:520 E:536 ||| NNP
,  ||| S:536 E:538 ||| ,
immunohistochemistry ||| S:538 E:558 ||| NN
,  ||| S:558 E:560 ||| ,
and  ||| S:560 E:564 ||| CC
whole-genome  ||| S:564 E:577 ||| JJ
microarray ||| S:577 E:587 ||| NN
,  ||| S:587 E:589 ||| ,
as  ||| S:589 E:592 ||| RB
well  ||| S:592 E:597 ||| RB
as  ||| S:597 E:600 ||| IN
real-time  ||| S:600 E:610 ||| JJ
transcriptional  ||| S:610 E:626 ||| JJ
analyses ||| S:626 E:634 ||| NNS
,  ||| S:634 E:636 ||| ,
were  ||| S:636 E:641 ||| VBD
performed.  ||| S:641 E:652 ||| CD
2 ||| S:652 E:653 ||| CD
)  ||| S:653 E:655 ||| -RRB-
Focused  ||| S:655 E:663 ||| NNP
radiation  ||| S:663 E:673 ||| NN
to  ||| S:673 E:676 ||| TO
the  ||| S:676 E:680 ||| DT
head  ||| S:680 E:685 ||| NN
and  ||| S:685 E:689 ||| CC
neck  ||| S:689 E:694 ||| NN
was  ||| S:694 E:698 ||| VBD
delivered  ||| S:698 E:708 ||| VBN
to  ||| S:708 E:711 ||| TO
mice  ||| S:711 E:716 ||| NNS
in  ||| S:716 E:719 ||| IN
a  ||| S:719 E:721 ||| DT
survival  ||| S:721 E:730 ||| NN
fashion ||| S:730 E:737 ||| NN
.  ||| S:737 E:739 ||| .
One  ||| S:739 E:743 ||| CD
month  ||| S:743 E:749 ||| NN
following  ||| S:749 E:759 ||| VBG
radiation ||| S:759 E:768 ||| NN
,  ||| S:768 E:770 ||| ,
vocal  ||| S:770 E:776 ||| JJ
fold  ||| S:776 E:781 ||| JJ
tissue  ||| S:781 E:788 ||| NN
was  ||| S:788 E:792 ||| VBD
analyzed  ||| S:792 E:801 ||| VBN
with  ||| S:801 E:806 ||| IN
histomorphometry ||| S:806 E:822 ||| NN
,  ||| S:822 E:824 ||| ,
immunohistochemistry ||| S:824 E:844 ||| NN
,  ||| S:844 E:846 ||| ,
and  ||| S:846 E:850 ||| CC
real-time  ||| S:850 E:860 ||| JJ
PCR  ||| S:860 E:864 ||| NNP
transcriptional  ||| S:864 E:880 ||| JJ
analysis  ||| S:880 E:889 ||| NN
for  ||| S:889 E:893 ||| IN
selected  ||| S:893 E:902 ||| JJ
markers  ||| S:902 E:910 ||| NN
of  ||| S:910 E:913 ||| IN
fibrosis ||| S:913 E:921 ||| NN
.  ||| S:921 E:923 ||| .
Human  ||| S:923 E:929 ||| NNP
irradiated  ||| S:929 E:940 ||| FW
vocal  ||| S:940 E:946 ||| FW
folds  ||| S:946 E:952 ||| FW
demonstrated  ||| S:952 E:965 ||| FW
increased  ||| S:965 E:975 ||| FW
collagen  ||| S:975 E:984 ||| FW
transcription ||| S:984 E:997 ||| FW
,  ||| S:997 E:999 ||| ,
with  ||| S:999 E:1004 ||| IN
increased  ||| S:1004 E:1014 ||| JJ
deposition  ||| S:1014 E:1025 ||| NN
and  ||| S:1025 E:1029 ||| CC
disorganization  ||| S:1029 E:1045 ||| NN
of  ||| S:1045 E:1048 ||| IN
collagen  ||| S:1048 E:1057 ||| NN
in  ||| S:1057 E:1060 ||| IN
both  ||| S:1060 E:1065 ||| PDT
the  ||| S:1065 E:1069 ||| DT
thyroarytenoid  ||| S:1069 E:1084 ||| JJ
muscle  ||| S:1084 E:1091 ||| NN
and  ||| S:1091 E:1095 ||| CC
the  ||| S:1095 E:1099 ||| DT
superficial  ||| S:1099 E:1111 ||| JJ
lamina  ||| S:1111 E:1118 ||| JJ
propria ||| S:1118 E:1125 ||| NN
.  ||| S:1125 E:1127 ||| .
Fibronectin  ||| S:1127 E:1139 ||| NNP
were  ||| S:1139 E:1144 ||| VBD
increased  ||| S:1144 E:1154 ||| VBN
in  ||| S:1154 E:1157 ||| IN
the  ||| S:1157 E:1161 ||| DT
superficial  ||| S:1161 E:1173 ||| JJ
lamina  ||| S:1173 E:1180 ||| JJ
propria ||| S:1180 E:1187 ||| NN
.  ||| S:1187 E:1189 ||| .
Laminin  ||| S:1189 E:1197 ||| NNP
decreased  ||| S:1197 E:1207 ||| VBD
in  ||| S:1207 E:1210 ||| IN
the  ||| S:1210 E:1214 ||| DT
thyroarytenoid  ||| S:1214 E:1229 ||| JJ
muscle ||| S:1229 E:1235 ||| NN
.  ||| S:1235 E:1237 ||| .
Whole  ||| S:1237 E:1243 ||| JJ
genome  ||| S:1243 E:1250 ||| JJ
microarray  ||| S:1250 E:1261 ||| JJ
analysis  ||| S:1261 E:1270 ||| NN
demonstrated  ||| S:1270 E:1283 ||| VBD
increased  ||| S:1283 E:1293 ||| VBN
transcription  ||| S:1293 E:1307 ||| VBN
of  ||| S:1307 E:1310 ||| IN
markers  ||| S:1310 E:1318 ||| NN
for  ||| S:1318 E:1322 ||| IN
fibrosis ||| S:1322 E:1330 ||| NN
,  ||| S:1330 E:1332 ||| ,
oxidative  ||| S:1332 E:1342 ||| JJ
stress ||| S:1342 E:1348 ||| NN
,  ||| S:1348 E:1350 ||| ,
inflammation ||| S:1350 E:1362 ||| NN
,  ||| S:1362 E:1364 ||| ,
glycosaminoglycan  ||| S:1364 E:1382 ||| JJ
production ||| S:1382 E:1392 ||| NN
,  ||| S:1392 E:1394 ||| ,
and  ||| S:1394 E:1398 ||| CC
apoptosis ||| S:1398 E:1407 ||| NN
.  ||| S:1407 E:1409 ||| .
Irradiated  ||| S:1409 E:1420 ||| FW
murine  ||| S:1420 E:1427 ||| FW
vocal  ||| S:1427 E:1433 ||| FW
folds  ||| S:1433 E:1439 ||| FW
demonstrated  ||| S:1439 E:1452 ||| FW
increases  ||| S:1452 E:1462 ||| NNS
in  ||| S:1462 E:1465 ||| IN
collagen  ||| S:1465 E:1474 ||| NN
and  ||| S:1474 E:1478 ||| CC
fibronectin  ||| S:1478 E:1490 ||| JJ
transcription  ||| S:1490 E:1504 ||| NN
and  ||| S:1504 E:1508 ||| CC
deposition  ||| S:1508 E:1519 ||| NN
in  ||| S:1519 E:1522 ||| IN
the  ||| S:1522 E:1526 ||| DT
lamina  ||| S:1526 E:1533 ||| JJ
propria ||| S:1533 E:1540 ||| NN
.  ||| S:1540 E:1542 ||| .
Transforming  ||| S:1542 E:1555 ||| VBG
growth  ||| S:1555 E:1562 ||| NN
factor  ||| S:1562 E:1569 ||| NN
( ||| S:1569 E:1570 ||| -LRB-
TGF ||| S:1570 E:1573 ||| NNP
) ||| S:1573 E:1574 ||| -RRB-
-Î²  ||| S:1574 E:1577 ||| NNP
increased  ||| S:1577 E:1587 ||| VBD
in  ||| S:1587 E:1590 ||| IN
the  ||| S:1590 E:1594 ||| DT
lamina  ||| S:1594 E:1601 ||| JJ
propria ||| S:1601 E:1608 ||| NN
.  ||| S:1608 E:1610 ||| .
Human  ||| S:1610 E:1616 ||| JJ
irradiated  ||| S:1616 E:1627 ||| JJ
vocal  ||| S:1627 E:1633 ||| JJ
folds  ||| S:1633 E:1639 ||| NNS
demonstrate  ||| S:1639 E:1651 ||| VBP
molecular  ||| S:1651 E:1661 ||| JJ
changes  ||| S:1661 E:1669 ||| NNS
leading  ||| S:1669 E:1677 ||| VBG
to  ||| S:1677 E:1680 ||| TO
fibrosis  ||| S:1680 E:1689 ||| VB
that  ||| S:1689 E:1694 ||| DT
underlie  ||| S:1694 E:1703 ||| JJ
loss  ||| S:1703 E:1708 ||| NN
of  ||| S:1708 E:1711 ||| IN
vocal  ||| S:1711 E:1717 ||| JJ
fold  ||| S:1717 E:1722 ||| NNS
pliability  ||| S:1722 E:1733 ||| VBP
occurring  ||| S:1733 E:1743 ||| VBG
in  ||| S:1743 E:1746 ||| IN
patients  ||| S:1746 E:1755 ||| NNS
following  ||| S:1755 E:1765 ||| VBG
laryngeal  ||| S:1765 E:1775 ||| JJ
irradiation ||| S:1775 E:1786 ||| NN
.  ||| S:1786 E:1788 ||| .
The  ||| S:1788 E:1792 ||| DT
irradiated  ||| S:1792 E:1803 ||| JJ
murine  ||| S:1803 E:1810 ||| JJ
tissue  ||| S:1810 E:1817 ||| NN
demonstrates  ||| S:1817 E:1830 ||| VBZ
similar  ||| S:1830 E:1838 ||| JJ
findings ||| S:1838 E:1846 ||| NNS
,  ||| S:1846 E:1848 ||| ,
and  ||| S:1848 E:1852 ||| CC
this  ||| S:1852 E:1857 ||| DT
mouse  ||| S:1857 E:1863 ||| NN
model  ||| S:1863 E:1869 ||| NN
may  ||| S:1869 E:1873 ||| MD
have  ||| S:1873 E:1878 ||| VB
utility  ||| S:1878 E:1886 ||| NN
in  ||| S:1886 E:1889 ||| IN
creating  ||| S:1889 E:1898 ||| VBG
prevention  ||| S:1898 E:1909 ||| NN
and  ||| S:1909 E:1913 ||| CC
treatment  ||| S:1913 E:1923 ||| NN
strategies  ||| S:1923 E:1934 ||| NNS
for  ||| S:1934 E:1938 ||| IN
vocal  ||| S:1938 E:1944 ||| JJ
fold  ||| S:1944 E:1949 ||| JJ
radiation  ||| S:1949 E:1959 ||| NN
fibrosis ||| S:1959 E:1967 ||| NN
.  ||| S:1967 E:1969 ||| .
